PlainRecalls
FDA Drug Moderate Class II Terminated

Imitrex STATdose System, Imitrex (sumatriptan succinate) Injection, 2 prefilled 0.5 mL syringe cartridges each containing 6 mg of sumatriptan for subcutaneous injection only, 1 imitrex STATdose Pen, 1 carrying case, Rx only, 6 mg, GlaxoSmithKline, Research Triangle Park, NC 27709, Made in Singapore, NDC 0173-0479-00

Reported: January 1, 2014 Initiated: November 6, 2013 #D-387-2014

Product Description

Imitrex STATdose System, Imitrex (sumatriptan succinate) Injection, 2 prefilled 0.5 mL syringe cartridges each containing 6 mg of sumatriptan for subcutaneous injection only, 1 imitrex STATdose Pen, 1 carrying case, Rx only, 6 mg, GlaxoSmithKline, Research Triangle Park, NC 27709, Made in Singapore, NDC 0173-0479-00

Reason for Recall

Lack of Assurance of Sterility: A small number of pre-filled syringes may contain needles which protrude through the needle shield.

Details

Recalling Firm
GlaxoSmithKline, LLC.
Units Affected
10,469 Systems
Distribution
Nationwide
Location
Zebulon, NC

Frequently Asked Questions

What product was recalled?
Imitrex STATdose System, Imitrex (sumatriptan succinate) Injection, 2 prefilled 0.5 mL syringe cartridges each containing 6 mg of sumatriptan for subcutaneous injection only, 1 imitrex STATdose Pen, 1 carrying case, Rx only, 6 mg, GlaxoSmithKline, Research Triangle Park, NC 27709, Made in Singapore, NDC 0173-0479-00. Recalled by GlaxoSmithKline, LLC.. Units affected: 10,469 Systems.
Why was this product recalled?
Lack of Assurance of Sterility: A small number of pre-filled syringes may contain needles which protrude through the needle shield.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 1, 2014. Severity: Moderate. Recall number: D-387-2014.